Sign Up to like & get
recommendations!
1
Published in 2020 at "Drugs"
DOI: 10.1007/s40265-020-01417-6
Abstract: Clascoterone (Winlevi®) is an androgen receptor inhibitor being developed as a topical cream and solution by Cassiopea (a spin-out company of Cosmo Pharmaceuticals) for the treatment of androgen-dependent skin disorders, including androgenetic alopecia and acne…
read more here.
Keywords:
androgen;
first approval;
treatment;
acne vulgaris ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Clinical therapeutics"
DOI: 10.1016/j.clinthera.2021.08.007
Abstract: PURPOSE Acne vulgaris is a ubiquitous condition in men and women starting in adolescence. It is often persistent and refractory to multiple treatment methods. Although multiple medications may be used on- or off-label for treatment,…
read more here.
Keywords:
first novel;
novel mechanism;
treatment;
acne vulgaris ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2021 at "Annals of Pharmacotherapy"
DOI: 10.1177/1060028021992053
Abstract: Objective: To review the efficacy and safety of clascoterone 1% cream for the treatment of acne vulgaris in patients 12 years of age and older. Data Sources: A literature search through PubMed, MEDLINE, and ClinicalTrials.gov…
read more here.
Keywords:
treatment;
topical androgen;
treatment acne;
clascoterone ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Drugs of today"
DOI: 10.1358/dot.2023.59.2.3507749
Abstract: Clascoterone is a novel topical antiandrogen medication approved for the treatment of acne. Conventional oral antiandrogen treatments targeting acne such as combined oral contraceptives and spironolactone exert systemic hormonal effects which commonly preclude their usage…
read more here.
Keywords:
treatment acne;
antiandrogen;
clascoterone treatment;
clascoterone ... See more keywords